Peter Kalix

2.9k total citations
46 papers, 2.3k citations indexed

About

Peter Kalix is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Peter Kalix has authored 46 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Toxicology, 27 papers in Cellular and Molecular Neuroscience and 23 papers in Clinical Psychology. Recurrent topics in Peter Kalix's work include Forensic Toxicology and Drug Analysis (29 papers), Psychedelics and Drug Studies (23 papers) and Neurotransmitter Receptor Influence on Behavior (19 papers). Peter Kalix is often cited by papers focused on Forensic Toxicology and Drug Analysis (29 papers), Psychedelics and Drug Studies (23 papers) and Neurotransmitter Receptor Influence on Behavior (19 papers). Peter Kalix collaborates with scholars based in Switzerland, France and United States. Peter Kalix's co-authors include Olav J. Braenden, Rudolf Brenneisen, S. Geisshüsler, Richard A. Glennon, Karoline Mathys, Hans‐Ulrich Fisch, Inayat Khan, Noreen Naiman, Philippe Roch and Paul Greengard and has published in prestigious journals such as Brain Research, Pharmacological Reviews and Journal of Neurochemistry.

In The Last Decade

Peter Kalix

45 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kalix Switzerland	24	1.4k	1.0k	851	350	317	46	2.3k
Marie Balı́ková Czechia	22	890 0.6×	518 0.5×	483 0.6×	236 0.7×	384 1.2×	60	2.0k
William Lee Hearn United States	29	798 0.6×	1.1k 1.1×	499 0.6×	597 1.7×	338 1.1×	47	2.4k
Hans Sachs Germany	30	888 0.6×	404 0.4×	209 0.2×	330 0.9×	321 1.0×	76	2.2k
W. D. Darwin United States	36	1.6k 1.2×	508 0.5×	278 0.3×	415 1.2×	1.2k 3.9×	60	3.2k
Manfred R. Moeller Germany	27	1.3k 0.9×	548 0.5×	298 0.4×	211 0.6×	1.4k 4.4×	44	2.7k
Marion Villain France	28	1.3k 1.0×	257 0.3×	318 0.4×	374 1.1×	219 0.7×	68	1.9k
Jon E. Sprague United States	25	928 0.7×	816 0.8×	577 0.7×	351 1.0×	440 1.4×	95	1.9k
Esther Papaseit Spain	23	716 0.5×	355 0.4×	452 0.5×	198 0.6×	528 1.7×	97	1.7k
Clara Pérez‐Mañá Spain	25	543 0.4×	425 0.4×	407 0.5×	257 0.7×	516 1.6×	100	2.0k
Raffaele Giorgetti Italy	24	839 0.6×	288 0.3×	389 0.5×	295 0.8×	355 1.1×	74	1.7k

Countries citing papers authored by Peter Kalix

Since Specialization

Citations

This map shows the geographic impact of Peter Kalix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kalix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kalix more than expected).

Fields of papers citing papers by Peter Kalix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kalix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kalix. The network helps show where Peter Kalix may publish in the future.

Co-authorship network of co-authors of Peter Kalix

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kalix. A scholar is included among the top collaborators of Peter Kalix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kalix. Peter Kalix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalix, Peter. (1996). Catha edulis, a plant that has amphetamine effects. Pharmacy World & Science. 18(2). 69–73. 98 indexed citations

Mathys, Karoline, et al.. (1994). Pharmacodynamics and pharmacokinetics of khat: A controlled study. Clinical Pharmacology & Therapeutics. 55(5). 556–562. 176 indexed citations

Kalix, Peter. (1994). Khat, an Amphetamine-like Stimulant. Journal of Psychoactive Drugs. 26(1). 69–74. 37 indexed citations

Kalix, Peter. (1992). Cathinone, a Natural Amphetamine. Pharmacology & Toxicology. 70(2). 77–86. 209 indexed citations

Kalix, Peter. (1991). The pharmacology of psychoactive alkaloids from Ephedra and Catha. Journal of Ethnopharmacology. 32(1-3). 201–208. 74 indexed citations

Kalix, Peter. (1990). Pharmacological properties of the stimulant khat. Pharmacology & Therapeutics. 48(3). 397–416. 154 indexed citations

Kalix, Peter, et al.. (1990). The khat alkaloid cathinone has amphetamine-like effects in humans. European Journal of Pharmacology. 183(2). 457–458. 6 indexed citations

Kalix, Peter. (1988). Khat: A plant with amphetamine effects. Journal of Substance Abuse Treatment. 5(3). 163–169. 79 indexed citations

Kalix, Peter. (1986). A comparison of the effects of some phenethylamines on the release of radioactivity from isolated rat caudate nucleus prelabelled with 3H-dopamine.. PubMed. 36(7). 1019–21. 1 indexed citations

10.

Kalix, Peter & Richard A. Glennon. (1986). Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochemical Pharmacology. 35(18). 3015–3019. 52 indexed citations

11.

Kalix, Peter. (1984). The pharmacology of khat. General Pharmacology The Vascular System. 15(3). 179–187. 118 indexed citations

12.

Kalix, Peter. (1984). RECENT ADVANCES IN KHAT RESEARCH. Alcohol and Alcoholism. 19(4). 319–23. 12 indexed citations

13.

Kalix, Peter. (1983). Effect of the alkaloid (−) cathinone on the release of radioactivity from rabbit atria prelabelled with 3H-norepinephrine. Life Sciences. 32(7). 801–807. 41 indexed citations

14.

Kalix, Peter. (1980). Hyperthermic response to (—)-cathinone, an alkaloid of Catha edulis (khat). Journal of Pharmacy and Pharmacology. 32(1). 662–663. 29 indexed citations

15.

Kalix, Peter. (1979). Prostaglandin E1 raises the cAMP content of peripheral nerve tissue. Neuroscience Letters. 12(2-3). 361–364. 13 indexed citations

16.

Kalix, Peter. (1976). Effect of decentralization and glucose withdrawal on the potassium-induced cAMP increase in the rabbit superior cervical ganglion. European Journal of Pharmacology. 39(2). 313–321. 7 indexed citations

17.

Kalix, Peter. (1976). Depolarizing media increase the guanosine 3′,5′‐monophosphate content of bovine superior cervical ganglion. Journal of Neurochemistry. 27(6). 1563–1564. 14 indexed citations

18.

Kalix, Peter & Philippe Roch. (1976). Evidence of depolarization-induced cAMP increase in the superior cervical ganglion of several mammalian species. General Pharmacology The Vascular System. 7(4). 267–270. 9 indexed citations

19.

Roch, Philippe & Peter Kalix. (1975). Adenosine 3',5'-monophosphate in bovine superior cervical ganglion: Effect of high extracellular potassium. Biochemical Pharmacology. 24(13-14). 1293–1296. 25 indexed citations

20.

Kalix, Peter & Philippe Roch. (1975). Effect of depolarizing agents on the adenosine-3?,5?-monophosphate content of the bovine superior cervical ganglion. Naunyn-Schmiedeberg s Archives of Pharmacology. 291(2). 131–137. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact